WebDisclosure WebDisclosure
Basculer en Français
9320 Companies
180533 Keywords
113982 Articles
97156 Press releases
Headlines Articles Press releases Max. Equity Marketing GmbH Remove
  1. Home
  2. Companies
  3. Max. Equity Marketing GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/17/2025 at 10:47, 1 month 29 days ago

    Max. Equity Marketing Forms Strategic Partnership for European Capital Market

    Investor Relations Strategic Partnership Innovative Solutions European Capital Market Industry Response
  • BRIEF

    published on 09/17/2025 at 10:47, 1 month 29 days ago

    Max. Equity Marketing forme un partenariat stratégique pour le marché européen des capitaux

    Partenariat Stratégique Relations Avec Les Investisseurs Solutions Innovantes Marché Européen Des Capitaux Réponse De L'industrie
  • PRESS RELEASE

    published on 09/17/2025 at 10:42, 1 month 29 days ago

    max. Equity Marketing: Strong Partnership for the European Capital Market // Maximilian Fischer and Manuel Taverne join forces, combining decades of experience and forming a strategic partnership

    max. Equity Marketing GmbH partners, Maximilian Fischer & Manuel Taverne, unite to offer expertise in capital markets. Innovative solutions for clients
    Innovative Solutions Partnership Capital Markets Expertise Equity Marketing
    Logo of Max. Equity Marketing GmbH
Accesswire
  • Published on 11/15/2025 at 18:10, 1 day 8 hours ago

    New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television

  • Published on 11/15/2025 at 01:40, 2 days ago

    Cyberlux Corporation Announces Operational Progress and Strategic Milestones in Q3 2025

  • Published on 11/15/2025 at 00:00, 2 days 2 hours ago

    Datametrex Announces Closing of Financings

  • Published on 11/14/2025 at 23:01, 2 days 3 hours ago

    55 North Mining Receives Drill Permits for Last Hope Gold Project and Announces Grant of Stock Options

  • Published on 11/14/2025 at 23:00, 2 days 3 hours ago

    Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights

View all ACCESSWIRE
EQS Group
  • Published on 11/15/2025 at 16:15, 1 day 10 hours ago

    Luxshare Precision Achieves a Two-Notch Upgrade to MSCI ESG Rating A, Demonstrating Continuous Strength in Sustainable Development

  • Published on 11/14/2025 at 20:40, 2 days 5 hours ago

    Dividend payment ex-date of Eleving Group

  • Published on 11/14/2025 at 19:15, 2 days 7 hours ago

    Exercise of Options Warrants

  • Published on 11/14/2025 at 18:40, 2 days 7 hours ago

    Holding(s) in Company

  • Published on 11/14/2025 at 18:20, 2 days 8 hours ago

    Relief Therapeutics Shareholders Approve Business Combination with NeuroX

View all EQS
Les Echos
  • Published on 11/16/2025 at 20:26, 6 hours 8 minutes ago

    Déclaration des transactions sur actions propres réalisées du 27 octobre au 31 octobre 2025

  • Published on 11/16/2025 at 20:26, 6 hours 8 minutes ago

    Disclosure of trading in own shares between October 27th and October 31st, 2025

  • Published on 11/14/2025 at 16:58, 2 days 9 hours ago

    Résultats trimestriels au 30 septembre 2025 - ANR par action en hausse de +2,14 % depuis le 1er janvier 2025 - Fonds propres consolidés : 698 M€

  • Published on 11/13/2025 at 18:30, 3 days 8 hours ago

    RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 13 NOVEMBRE 2025

  • Published on 11/13/2025 at 18:30, 3 days 8 hours ago

    RESULTS OF THE COMBINED GENERAL MEETING ON NOVEMBER 13, 2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy